Biocompatibility tissue compatibility

Although the initially reported tissue compatibility tests for subcutaneous implants of poly(BPA-iminocarbonate) were encouraging (41,42), it is doubtful whether this polymer will pass more stringent biocompatibility tests. In correspondence with the properties of most synthetic phenols, BPA is a known irritant and most recent results indicate that BPA is cytotoxic toward chick embryo fibroblasts in vitro (43). Thus, initial results indicate that poly(BPA-iminocarbonate) is a polymer with highly promising material properties, whose ultimate applicability as a biomaterial is questionable due to the possible toxicity of its monomeric building blocks. 

In order to test the tissue compatibility of tyrosine-derived poly-(iminocarbonates), solvent cast films of poIy(CTTH) were subcutaneously implanted into the back of outbread mice. In this study, conventional poly(L-tyrosine) served as a control (42). With only small variations, the experimental protocol described for the biocompatibility testing of poly(N-palmitoylhydroxyproline ester) (Sec. III. 

Initial tests in the rat revealed a high degree of tissue compatibility of Dat-Tyr-Hex derived polymers. More detailed tests are now in progress. In addition, tyrosine derived polymers are currently being evaluated in the formulation of an intracranial controlled release device for the release of dopamine, in the design of an intraarterial stent (to prevent the restenosis of coronary arteries after balloon angioplasty), and in the development of orthopedic implants. The use of tyrosine derived polymers in these applications will provide additional data on the biocompatibility of these polymers. 

Biocompatibility (See Table 1), which is a phenomenological concept, is the essential property of biomaterials. For instance, the inner surface of an implanted vascular graft or blood pump (artificial heart) must be blood-compatible, while its outer surface must be tissue-compatible. In other words, the material surfaces must not exert any adverse elfects upon blood or tissue, or upon other biological elements at the interfaces. 

Historically, in vivo biocompatibility has been qualitatively assessed by histological evaluation of explanted devices.6 The presence or absence of specific inflammatory and fibrotic cell types and the degree and duration of the incidence of these cells at the implant site can be correlated to arelative degree of success or failure in terms of tissue compatibility. However, this common implant, sacrifice, explant, and evaluate single-time-point-per-animal approach is quite limited in assessment of time-depen-dent phenomena (e.g., direct assay of molecular and cellular mediators) associated with the progression of the inflammatory response and the development of the FBR. 

The results by Hetrick et al.32 support the use of NO-release coatings for developing more tissue-compatible sensors. However, the impact of NO on the biocompatibility at a NO-releasing implant is a multifaceted question that is still not fully understood. Further study into the mechanisms by which NO decreases tissue encapsulation and chronic immune response while increasing angiogenesis will aid in optimization of the NO release properties (e.g., flux, concentration, and duration) of an implant coating for sensor applications. 

E.K. Yim, liao I-c, K.W. Leong, Tissue compatibility of interfacial polyelectrolyte complexation fibrous scaffold evaluation of blood compatibility and biocompatibility. Tissue Eng. 13 (2007) 423-433. 

Other Cell Culture-Based Assays for Cell/Tissue Compatibility In addition biocompatibility behavior can be evaluated by seeding cells directly on the test material (similar to the wash-and-plate assay described in Section 4.4.8) and subsequent analysis of cell adhesion, cell proliferation, cell morphology, and cytoskeletal organization and the presence of cell-secreted extracellular matrix (ECM). A proper cell adhesion and the formation of ECM proteins, like fibronectin, are, for instance, essential steps for successful tissue integration of biomaterials. 

Biocompatibility investigations on artificial blood vessels made from polyethylene terephthalate show good in-vivo tissue compatibility. Investigations of porous, textile blood vessel implants show that connective tissue formed within 28 days within the textile material. However, this tissue differs from normal connective tissue. With increasing implantation time, a reduction in molecular mass has been observed bursting strength was reduced to 25% after 13.5 years, which is considered sufficient for this application [988]. 

As shown in Fig. 3, there are many aspects of interfacial biocompatibility. In this subsection typical interfacial biocompatibility, blood compatibility, and tissue connectivity will be explained. 

The present study focuses on elucidating and quantifying the physical changes in the polymers that were induced by the PEG-modulation of the PHB-synthesis. PEG is a polyether that is known for its exceptional blood and tissue compatibility, it is used extensively as stealth material in a variety of drug delivery vehicles and is also under investigation as surface coating for biomedical implants. PEG, when dissolved in water, has a low interfacial free ener, exhibits rapid chain motion, and its lai e excluded volume leads to steric repulsion of approaching molecules (16, 17). These properties are responsible for the superb biocompatibility of PEG. However, PEG is not a thermoplastic material and therefore not moldable. Furthermore, a PEG-modified alizarin dye is used for modulated fermentation in order to synthesize colored bacterial PHB. 

Biocompatible Biologically compatible to host tissue (i.e., should not provoke any rejection, inflammation, and immune responses). 

The choice of a particular inactive ingredient and its concentration is based not only on physical and chemical compatibility, but also on biocompatibility with the sensitive and delicate ocular tissues. Because of the latter requirement, the use of inactive ingredients is greatly restricted in ophthalmic dosage forms. 

Polyelectrolytes have been widely investigated as components of biocompatible materials. Biomaterials come into contact with blood when used as components in invasive instruments, implant devices, extracorporeal devices in contact with blood flow, implanted parts of hard structural elements, implanted parts of organs, implanted soft tissue substitutes and drug delivery devices. Approaches to the development of blood compatible materials include surface modification to give blood compatibility, polyelectrolyte-based systems which adsorb and/or release heparin as well as polyelectrolytes which mimic the biological activity of heparin. 

The response reaction of the host to a foreign material remaining in the body for an extended period of time is a concern. Thus, any polymeric material to be integrated into such a delicate system as the human body must be biocompatible. Biocompatibility is defined as the ability of a material to perform with an appropriate host response in a specific application [79]. The concept include all aspects of the interfacial reaction between a material and body tissues initial events at the interface, material changes over time, and the fate of its degradation products. To be considered bio compatible, a biodegradable polymer must meet a number of requirements, given in Table 2. 

Hu, K., Lv, Q., Cui, F.Z., Feng, Q.L., Kong, X.D., Wang, H.L., Huang, L.Y., and Li, T. "Biocompatible fibroin blended films with recombinant human-like collagen for hepatic tissue engineering". J. Bioact. Compat. Polym. 21(1), 23-37 (2006a). 

The conclusion drawn from the above-discussed features of native endothelium is that—where feasible—construction of host endothelium on the surface of synthetic implants—i.e. engineered endothelialization—may present a promising pathway for fundamentally resolving the biocompatibility and bio-functionality of artificial cardiovascular transplantation. This proposed biocompatibility is, however, not simply thromboresistance (or blood compatibility) plus blood-cell compatibility, but a real bioactive, self-renewable and specifically functional alliance of tissues and synthetics. 

---